9 Meters Biopharma Inc (NMTRQ) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX17,137.07+0.40%+68.64DAX17,137.070.40%
FTSE 1007,655.62-0.82%-63.59FTSE 1007,655.620.82%
CAC 407,810.53+0.20%+15.31CAC 407,810.530.20%
IBEX 3510,110.70+0.72%+72.50IBEX 3510,110.700.72%
STOXX 504,777.72+0.37%+17.44STOXX 504,777.720.37%

HomeNMTRQ • OTCMKTS

9 Meters Biopharma Inc

$0.00

Feb 20, 8:10:00 PM GMT-5 · USD · OTCMKTS · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Calithera Biosciences Inc

$0.030

CALA0.00%

Tetralogic Pharmaceuticals Corp

$0.00010

TLOG9,900.00%

Amarantus Bioscience Holdings Inc

$0.00030

AMBS0.00%

RegenETP, Inc

$0.100

RGTPQ0.00%

ContraFect Corp

$0.028

CFRXQ8.03%

Biocept Inc

$0.00010

BIOCQ50.00%

Absci Corp

$4.81

ABSI9.76%

AC Immune SA

$3.33

ACIU8.82%

Acumen Pharmaceuticals Inc

$3.32

ABOS1.22%

Antelope Enterprise Holdings Ltd

$2.10

AEHL8.81%

Market news

UKX0.82%

FTSE 100 Index

.INX0.60%

S&P 500

HSBA7.56%

HSBC Holdings plc

UKX0.82%

FTSE 100 Index

GLEN1.97%

Glencore PLC

Financials

Income Statement

Revenue

Net income

(USD)Mar 2023info

Fiscal Q1 2023 ended 3/31/23.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

Operating expense

Represents the total incurred expenses through normal operations

12.79M12.52%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-13.87M-22.17%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-1.02-27.50%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-12.79M-12.53%

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Mar 2023info

Fiscal Q1 2023 ended 3/31/23.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

6.94M-81.37%

Total assets

The total amount of assets owned by a company

9.31M-76.28%

Total liabilities

Sum of the combined debts a company owes

15.61M87.59%

Total equity

The value of subtracting the total liabilities from the total assets of a company

-6.30M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

14.46M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

-0.00

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-150.58%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-304.46%

Net change in cash

(USD)Mar 2023info

Fiscal Q1 2023 ended 3/31/23.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-13.87M-22.17%

Cash from operations

Net cash used or generated for core business activities

-9.75M-0.01%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

-12.29M

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

-22.04M-125.98%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

10.39M288.88%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on OTCMKTS

US headquartered

Headquartered in Raleigh, North Carolina, United States

Previous close

The last closing price

$0.00

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

10.00 USD

Avg Volume

The average number of shares traded each day over the past 30 days

9.10K

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

OTCMKTS

About

Founded

2012

Headquarters

Raleigh, North CarolinaUnited States

Employees

10

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexFTSE 100 Index7,655.620.82%
IndexDow Jones Industrial Average38,563.800.17%
IndexFTSE 250 Index19,108.650.0051%
TSLATesla Inc$193.763.10%
LLOYLloyds Banking Group PLCGBX43.650.011%
BPBP plcGBX468.660.45%
AMZNAmazon.com Inc$167.081.43%
IndexFTSE All-Share Index4,177.470.68%
RRRolls-Royce Holdings PLCGBX326.331.26%
BARCBarclays PLCGBX163.611.12%
AAPLApple Inc$181.560.41%
LLoews Corp$73.870.55%
SMTScottish Mortgage Investment Trust PLCGBX768.400.21%
BT.ABT Group - CLASS A Common StockGBX109.052.06%
GMGeneral Motors Co$39.010.80%
DGEDiageo plcGBX2,978.500.40%
EZJeasyJet plcGBX554.400.72%

People also search for

CALACalithera Biosciences Inc$0.0300.00%
TLOGTetralogic Pharmaceuticals Corp$0.000109,900.00%
AMBSAmarantus Bioscience Holdings Inc$0.000300.00%
RGTPQRegenETP, Inc$0.1000.00%
CFRXQContraFect Corp$0.0288.03%
BIOCQBiocept Inc$0.0001050.00%
ABSIAbsci Corp$4.819.76%
ACIUAC Immune SA$3.338.82%
ABOSAcumen Pharmaceuticals Inc$3.321.22%
AEHLAntelope Enterprise Holdings Ltd$2.108.81%
AGRIAgriFORCE Growing Systems Ltd$0.2725.75%
AEIAlset Inc$1.072.40%
MASS908 Devices Inc.$7.121.52%
ETNB89bio Inc$9.891.54%
FEAM5E Advanced Materials Inc$1.1710.38%
EGHT8x8 Inc$2.581.15%
FDMT4D Molecular Therapeutics Inc$27.390.48%
ABVCABVC Biopharma Inc$1.205.51%

9 Meters Biopharma Inc (NMTRQ) Stock Price & News - Google Finance (7)HelpSend feedbackPrivacyTermsDisclaimer

9 Meters Biopharma Inc (NMTRQ) Stock Price & News - Google Finance (2024)
Top Articles
Latest Posts
Article information

Author: Velia Krajcik

Last Updated:

Views: 5394

Rating: 4.3 / 5 (74 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Velia Krajcik

Birthday: 1996-07-27

Address: 520 Balistreri Mount, South Armand, OR 60528

Phone: +466880739437

Job: Future Retail Associate

Hobby: Polo, Scouting, Worldbuilding, Cosplaying, Photography, Rowing, Nordic skating

Introduction: My name is Velia Krajcik, I am a handsome, clean, lucky, gleaming, magnificent, proud, glorious person who loves writing and wants to share my knowledge and understanding with you.